Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Revenue

Pharmosa Biopharm had revenue of 4.80M TWD in the quarter ending September 30, 2026, with 20.15% growth. This brings the company's total for the last twelve months to 54.19M, down -60.37% year-over-year. In the year 2025, Pharmosa Biopharm had annual revenue of 67.27M, down -59.86%. That makes Pharmosa Biopharm the 42,770th largest company in the world by revenue and 2,145th in Taiwan.

• Revenue (ttm): 54.19M
• Revenue Growth: -60.37%
• P/S Ratio: 60.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.28B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 167.49M 100.0%
• Taiwan 75.00K 0.0%

Fiscal year ended Dec 31, 2024 See the full Pharmosa Biopharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.27M	-100.30M	-59.86%
Dec 31, 2024	167.57M	-146.93M	-46.72%
Dec 31, 2023	314.50M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error